{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:41:06Z","timestamp":1781304066711,"version":"3.54.1"},"reference-count":39,"publisher":"The Journal of Rheumatology","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Renal biopsy is the \u201cgold standard\u201d to determine renal activity in systemic lupus erythematosus (SLE), but it is expensive, invasive, and carries risk. Osteoprotegerin (OPG) is produced by the heart, lungs, kidney, and bone. Monocyte chemoattractant protein-1 (MCP-1), a chemotactic cytokine, is involved in the progression of glomerular and tubulointerstitial injury. We investigated both urine OPG and MCP-1 as potential biomarkers for lupus nephritis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Our subjects, 87 patients with SLE (88% women; 48% African American, 41% Caucasian, 11% other), mean age 44 years, were followed monthly to quarterly. Urinary OPG (pg\/ml) and MCP-1 (pg\/ml) were measured (Luminex MAP bead assay).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>OPG concentrations were strongly associated with global disease activity and with both renal activity on a visual analog scale (VAS) (p = 0.0006) and renal disease activity descriptors of the SELENA SLEDAI, including hematuria (p = 0.001) and a positive anti-dsDNA (p = 0.013). MCP-1 was also associated with the renal VAS (p = 0.032), renal disease activity descriptors of SELENA SLEDAI, including hematuria (p = 0.027), and with a positive anti-dsDNA (p = 0.016). We also examined the relationship between the biomarkers and having a urine protein to creatinine ratio (pr\/cr) \u2265 0.5. Among patients with medium or high OPG, 46% had urine pr\/cr \u2265 0.5, compared to only 23% among those with low OPG (p = 0.032). The 2 biomarkers were strongly correlated with each other (Spearman correlation coefficient 0.77, p &lt; 0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>The lack of availability of urine biomarkers has hampered development of new therapies for lupus nephritis. Urine MCP-1 and OPG were both associated with measures of lupus renal disease activity. Medium or high levels of OPG were predictive of a urine protein\/creatinine ratio of \u2265 0.5. Further study, including longitudinal assessment and correlation with concurrent renal biopsies, is necessary before this assay can be used in the routine clinic setting.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.081112","type":"journal-article","created":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T01:26:20Z","timestamp":1249089980000},"page":"2224-2230","source":"Crossref","is-referenced-by-count":57,"title":["Urine Osteoprotegerin and Monocyte Chemoattractant Protein-1 in Lupus Nephritis"],"prefix":"10.3899","volume":"36","author":[{"given":"ADNAN N.","family":"KIANI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KRISTEN","family":"JOHNSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CATHERINE","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EDWARD","family":"DIEHL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUAIZHONG","family":"HU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GANESH","family":"VASUDEVAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SUKHMINDER","family":"SINGH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LAURENCE S.","family":"MAGDER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STUART J.","family":"KNECHTLE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHELLE","family":"PETRI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2009,7,31]]},"reference":[{"key":"2018112909212701000_36.10.2224.1","first-page":"1620","article-title":"High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients","volume":"10","author":"Austin","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"2018112909212701000_36.10.2224.2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.162"},{"key":"2018112909212701000_36.10.2224.3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel347"},{"key":"2018112909212701000_36.10.2224.4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.9.4818"},{"key":"2018112909212701000_36.10.2224.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80209-3"},{"key":"2018112909212701000_36.10.2224.6","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.4049\/jimmunol.161.11.6113","article-title":"OPG\/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40","volume":"161","author":"Yun","year":"1998","journal-title":"J Immunol"},{"key":"2018112909212701000_36.10.2224.7","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.1.2"},{"key":"2018112909212701000_36.10.2224.8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010153200"},{"key":"2018112909212701000_36.10.2224.9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.2.631"},{"key":"2018112909212701000_36.10.2224.10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020775"},{"key":"2018112909212701000_36.10.2224.11","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490039"},{"key":"2018112909212701000_36.10.2224.12","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.346"},{"key":"2018112909212701000_36.10.2224.13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0272-6386(96)90097-9","article-title":"MCP-1 levels in patients with glomerular disease","volume":"27","author":"Rovin","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"2018112909212701000_36.10.2224.14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1098-2825(1998)12:1<1::AID-JCLA1>3.0.CO;2-F","article-title":"Urinary levels of MCP-1 and disease activity in patients with IgA nephropathy","volume":"12","author":"Saitoh","year":"1998","journal-title":"Clin Lab Anal"},{"key":"2018112909212701000_36.10.2224.15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0065-2776(08)60509-X","article-title":"IL-8 and related chemotactic cytokines \u2014 CXC and CC chemokines","volume":"55","author":"Baggiolini","year":"1994","journal-title":"Adv Immunol"},{"key":"2018112909212701000_36.10.2224.16","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.4049\/jimmunol.144.8.3034","article-title":"MCP-1 and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor","volume":"144","author":"Sica","year":"1990","journal-title":"J Immunol"},{"key":"2018112909212701000_36.10.2224.17","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.4049\/jimmunol.150.5.1971","article-title":"Regulation of MCP-1 and macrophage colony stimulating factor-1 by IFN-gamma, tumor necrosis factor-alpha, IgG aggregates, and cAMP in mouse mesangial cells","volume":"150","author":"Satriano","year":"1993","journal-title":"J Immunol"},{"key":"2018112909212701000_36.10.2224.18","first-page":"740","article-title":"Monocyte chemoattractant protein-1: Plasma concentrations and A(\u22122518)G promoter polymorphism of its gene in systemic lupus erythematosus","volume":"34","author":"Brown","year":"2007","journal-title":"J Rheumatol"},{"key":"2018112909212701000_36.10.2224.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-003-0124-4"},{"key":"2018112909212701000_36.10.2224.20","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/ajkd.1998.v31.pm9631856","article-title":"Chemotactic factors and renal inflammation","volume":"31","author":"Rovin","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"2018112909212701000_36.10.2224.21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ki.1996.105","article-title":"Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis","volume":"49","author":"Wada","year":"1996","journal-title":"Kidney Int"},{"key":"2018112909212701000_36.10.2224.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.20266"},{"key":"2018112909212701000_36.10.2224.23","first-page":"804","article-title":"MCP-1 is excreted in excessive amounts in the urine of patients with LN","volume":"73","author":"Noris","year":"1995","journal-title":"Lab Invest"},{"key":"2018112909212701000_36.10.2224.24","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0796"},{"key":"2018112909212701000_36.10.2224.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.10.006"},{"key":"2018112909212701000_36.10.2224.26","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00016.2008"},{"key":"2018112909212701000_36.10.2224.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051135"},{"key":"2018112909212701000_36.10.2224.28","first-page":"53","article-title":"Validity and reliability of lupus activity measures in the routine clinic setting","volume":"19","author":"Petri","year":"1992","journal-title":"J Rheumatol"},{"key":"2018112909212701000_36.10.2224.29","doi-asserted-by":"publisher","DOI":"10.1002\/art.23456"},{"key":"2018112909212701000_36.10.2224.30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0272-6386(95)90595-2","article-title":"Changes in antibodies to C1q predict renal relapse in system lupus erythematosus","volume":"26","author":"Coremans","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"2018112909212701000_36.10.2224.31","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A"},{"key":"2018112909212701000_36.10.2224.32","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200110)44:10<2342::AID-ART397>3.0.CO;2-8"},{"key":"2018112909212701000_36.10.2224.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.06.126"},{"key":"2018112909212701000_36.10.2224.34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ki.1996.105","article-title":"Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis","volume":"49","author":"Wada","year":"1996","journal-title":"Kidney Int"},{"key":"2018112909212701000_36.10.2224.35","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.293"},{"key":"2018112909212701000_36.10.2224.36","first-page":"804","article-title":"Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis","volume":"73","author":"Noris","year":"1995","journal-title":"Lab Invest"},{"key":"2018112909212701000_36.10.2224.37","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.7.1662"},{"key":"2018112909212701000_36.10.2224.38","doi-asserted-by":"publisher","DOI":"10.1159\/000045663"},{"key":"2018112909212701000_36.10.2224.39","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004080658"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.081112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T06:12:29Z","timestamp":1685081549000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.081112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,31]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,10,8]]},"published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.3899\/jrheum.081112"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.081112","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,31]]}}}